SHA:600566 Revenue

Hubei Jumpcan Pharmaceutical had revenue of 1.77B CNY in the quarter ending September 30, 2024, a decrease of -7.18%. This brings the company's revenue in the last twelve months to 8.92B, down -7.43% year-over-year. In the year 2023, Hubei Jumpcan Pharmaceutical had annual revenue of 9.65B with 7.32% growth.

Revenue (ttm)

8.92B

Revenue Growth

-7.43%

P/S Ratio

2.92

Revenue / Employee

1.71M

Employees

5,230

Market Cap

26.11B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.65B	658.17M	7.32%
Dec 31, 2022	9.00B	1.37B	17.90%
Dec 31, 2021	7.63B	1.47B	23.77%
Dec 31, 2020	6.16B	-775.02M	-11.17%
Dec 31, 2019	6.94B	-268.21M	-3.72%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	26.00B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Yunnan Baiyao Group Co.,Ltd	39.34B
Shanghai United Imaging Healthcare	10.30B
Sichuan Biokin Pharmaceutical	5.82B

Revenue Rankings